Poor detoxification capabilities and chronic toxicity are fundamental aspects of autism spectrum disorders with detoxification protocols being imperative to success- ful outcomes. Improperly designed protocols can lead to unwanted symptoms that makes these much-needed therapies difficult to continue.
Speaker: Christopher Shade, PhD
Christopher Shade, PhD, is the founder and CEO of Quicksilver Scientific®, a nanoparticle dietary supplement company located in Louisville, Colorado. Dr. Shade’s background is deeply rooted in the biological, environmental, and analytical chemistry of mercury in all its forms and their interactions with sulfur compounds, particularly glutathione and its enzyme system making him an expert in heavy metals toxicity and detoxification. He has patented a mercury speciation diagnostic process to analyze human toxicity, founded the only clinical lab in the world offering mercury speciation analysis, and has designed cutting-edge dietary supplements and protocols for detoxification, immune and foundational wellness, and longevity using Quicksilver Delivery Systems® technology. This patent-pending nanoparticle delivery technology supports the bioavailability of difficult to absorb compounds for higher efficacy. Dr. Shade is regularly sought out to speak as an educator on the topics of mercury, environmental toxicities, the human detoxification system, longevity, immune health, and the functional applications of dietary supplements in the U.S. and internationally.
